Ardelyx Inc. ARDX, -0.58% on Tuesday won its long fight for U.S. regulatory approval of a treatment designed to help patients with chronic kidney disease.…
breakingnow_w51jcqOctober 17, 2023
Ardelyx Inc. Ardelyx, Inc. is a biopharmaceutical company. engages in the research, development and commercialization of medicine for the treatment of cardiorenal diseases. Its product…
breakingnow_w51jcqMarch 3, 2023
Ardelyx Inc. ARDX, +5.02% stock is up 5.2% in premarket trades on Thursday after the Waltham, Mass., biopharmaceutical company said the U.S. Food and Drug…
breakingnow_w51jcqDecember 29, 2022
